Net profit of Orchid Pharma declined 49.20% to Rs 14.91 crore in the quarter ended June 2025 as against Rs 29.35 crore during the previous quarter ended June 2024. Sales declined 29.25% to Rs 172.93 crore in the quarter ended June 2025 as against Rs 244.41 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 172.93 | 244.41 | -29 |
| OPM % | 8.19 | 13.29 | - |
| PBDT | 22.37 | 36.56 | -39 |
| PBT | 13.71 | 28.12 | -51 |
| NP | 14.91 | 29.35 | -49 |